Are there any abnormalities in lipid profile of post-COVID patients: A case–control study?

Background: It is well known that viral infections alter lipid metabolism in a way that promotes viral proliferation. Numerous studies have shown that people with coronavirus disease-2019 (COVID-19) have a significant impact on patients’ lipid profiles. To evaluate whether any lipid profile aberrati...

Full description

Saved in:
Bibliographic Details
Main Authors: Sritama Paul, Pritama Paul, Mousumi Mukhopadhyay, Niladri Sarkar, Uttam Kumar Paul
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2023-01-01
Series:Annals of Medical Science and Research
Subjects:
Online Access:https://journals.lww.com/10.4103/amsr.amsr_52_22
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Background: It is well known that viral infections alter lipid metabolism in a way that promotes viral proliferation. Numerous studies have shown that people with coronavirus disease-2019 (COVID-19) have a significant impact on patients’ lipid profiles. To evaluate whether any lipid profile aberrations are still present in those who had COVID-19 infection more than 6 months ago, our purpose is to compare the lipid abnormalities in post-COVID patients to those in non-COVID patients. Methods: We have taken blood samples from 108 post-COVID-19 patients (cases) and 108 nonsmokers who are age- and sex-matched as controls. Using the blood sample, a lipid profile test was conducted to measure total cholesterol, high-density lipoprotein, low-density lipoprotein (LDL), very LDL, and triglycerides. Results: Data analysis demonstrates that all of the results are statistically significant, with the exception of the LDL cholesterol (LDL-C) value, which is statistically nonsignificant. Conclusion: With the exception of the LDL-C value in post-COVID-19 individuals, we were able to identify noticeable alterations in lipid profiles. It is a fact that most investigations have found abnormalities in lipid profiles during the disease’s acute phase. Future studies must examine whether the lipid profiles of individuals after COVID-19 underwent any discernible changes with a larger sample size and a longer study period.
ISSN:2949-785X
2949-7868